SmarterDividends
TKPHF

Takeda Pharmaceutical Company Limited

TKPHF

Healthcare · Stock · semiannual payer

$31.19

Undervalued · +43% Add to Portfolio

Forward Yield

4.16%

Annual Dividend

$1.30

Payout Ratio

167%

5-Yr Growth

-4.8%

Ex-Date

Sep 30, 2026

Frequency

Semiannual

Summary

As of July 2026, Takeda Pharmaceutical Company Limited (TKPHF) yields 4.16% ($1.30 per share annually), with a blended fair-value estimate of $44.68 — +43% upside, so it screens as undervalued. Dividend safety grade: C (53/100). 1 years of dividend growth.

Is TKPHF a good dividend stock?

Mixed

Takeda Pharmaceutical Company Limited (TKPHF) pays a semiannual dividend yielding 4.16% ($1.30/yr), with 1 year of growth and a dividend-safety grade of C. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.

Advantages

    Risks

    • Cut its dividend in 2023
    • Elevated payout ratio (167%)
    • Dividend has been shrinking, not growing
    • Share price is down over the past 5 years

    Key Data

    Dividend Yield
    4.16%
    Payout Ratio
    167%
    Annual Dividend
    $1.30
    5-Yr Avg Growth
    -4.8%
    Ex-Dividend Date
    Sep 30, 2026
    Years of Growth
    1
    Frequency
    semiannual
    Beta
    0.09
    Market Cap
    $49.8B
    P/E Ratio
    5-Yr Total Return
    -8%
    52-Week Range
    $26.33 – $39.20
    Dividend Safety
    C · 53/100
    Ever Cut?
    Yes (2023)
    TKPHF ex-dividend date & scheduleNext ex-date Sep 30, 2026 · full ex-dividend historyView →

    Frequently Asked Questions

    Income Calculator

    At $1.30 / yr per share

    Per payment (semiannual)$65.00
    Annual$130.00
    Monthly avg$10.83